SKIBSTED RUSSELL 4
4 · BIOTIME INC · Filed Dec 20, 2018
Insider Transaction Report
Form 4
BIOTIME INCBTX
SKIBSTED RUSSELL
Chief Financial Officer
Transactions
- Tax Payment
Common Shares, no par value
2018-12-18$1.03/sh−7,781$8,014→ 24,078 total - Exercise/Conversion
Common Shares, no par value
2018-12-18+22,500→ 31,859 total - Exercise/Conversion
Restricted Stock Units
2018-12-18−22,500→ 11,250 totalExercise: $0.00→ Common Shares (22,500 underlying)
Footnotes (4)
- [F1]Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units ("RSUs") granted to the Reporting Person on May 24, 2018.
- [F2]Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options.
- [F3]Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 22,500 RSUs, the grant of which was previously reported on a Form 8-K.
- [F4]25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, 50% of the RSUs vested on December 18, 2018, then the remaining 25% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.